- Messages
- 819
- Likes
- 1,448
Hi all,
I asked in the help-apheresis thread but haven't gotten any responses, so I thought I'd make a new thread so it doesn't get lost.
Have any of you tried the Pretorius paper protocol to treat potential microclots after covid?
Someone had shared it a few months ago - see attached.
My GP is open to the idea of trialling it but I thought I'd check before I bother getting into something like this.
The main protocol in brief is:
Thanks!
I asked in the help-apheresis thread but haven't gotten any responses, so I thought I'd make a new thread so it doesn't get lost.
Have any of you tried the Pretorius paper protocol to treat potential microclots after covid?
Someone had shared it a few months ago - see attached.
My GP is open to the idea of trialling it but I thought I'd check before I bother getting into something like this.
The main protocol in brief is:
A subset of 24 patients was treated with
one month of dual antiplatelet therapy (DAPT) (Clopidogrel 75mg/Aspirin 75mg) once a day,
as well as a direct oral anticoagulant (DOAC) (Apixiban) 5 mg twice a day. A proton pump
inhibitor (PPI) pantoprazole 40 mg/day was also prescribed for gastric protection. Such a
regime must only be followed under strict and qualified medical guidance to obviate any
dangers, especially haemorrhagic bleeding, and of the therapy as a whole.
Thromboelastography (TEG®
) was used to assist in determining their clotting status. Each of
the 24 treated cases reported that their main symptoms were resolved and fatigue as the main
symptom was relieved, and this was also reflected in a decrease of both the fibrin amyloid
microclots and platelet pathology scores.
one month of dual antiplatelet therapy (DAPT) (Clopidogrel 75mg/Aspirin 75mg) once a day,
as well as a direct oral anticoagulant (DOAC) (Apixiban) 5 mg twice a day. A proton pump
inhibitor (PPI) pantoprazole 40 mg/day was also prescribed for gastric protection. Such a
regime must only be followed under strict and qualified medical guidance to obviate any
dangers, especially haemorrhagic bleeding, and of the therapy as a whole.
Thromboelastography (TEG®
) was used to assist in determining their clotting status. Each of
the 24 treated cases reported that their main symptoms were resolved and fatigue as the main
symptom was relieved, and this was also reflected in a decrease of both the fibrin amyloid
microclots and platelet pathology scores.
Attachments
-
1.6 MB Views: 14